Hanai Y†*, Ueda T, Hamada Y, Oda K, Takahashi Y, Nakajima K, Miyazaki Y, Kiriyama M, Uekusa S†, Matsuo K†, et al. Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patients. Mycoses. 2023. 66. 1035-1044
Shusuke Uekusa†*, Yuki Hanai†, Shinobu Hirayama, Takuya Yokoo, Tetsuya Hasegawa, Kohei Shimoyama, Ayumu Kusano, Kenji Nishizawa, Takahiro Matsumoto, Kazuhiro Matsuo†. Vancomycin Hydrochloride as a Risk Factor for Acute Kidney Injury: A Retrospective Study. Pharmacology. 2023. 108. 5. 444-450
Shusuke Uekusa†*, Maho Nemoto, Yuki Hanai†, Misaki Nakashin, Arisu Miyagawa, Sachiko Yanagino, Yoshiki Arita, Takahiro Matsumoto, Kenji Nishizawa, Hidenari Nagai†, et al. Risk factors for Lenvatinib-induced high-grade hypothyroidism in patients with hepatocellular carcinoma: A retrospective study. Pharmacology. 2023. 108. 5. 460-468
Uekusa S†*, Matsuo K†, Hanai Y†, Suzuki T, Matsumoto T, Tsuruoka F, Nakatani M, Sekine Y, Ishigooka J, Watanabe H, et al. Effect of benzodiazepine tapering on activity-sleep in patients with psychiatric disorders using actigraphy: A prospective study. 日本精神薬学会誌. 2022. 6. 41-51